SCHEMBL21398

SCHEMBL21398

COCCOC1(C(=N)NC(=O)O)CCC(c2nc3c(-c4cnn(-c5ccccc5)c4)cnn3c(N)c2I)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 9/20 0.39
CCNA2 P20248 9/20 0.39
CDK2 P24941 9/20 0.39
CCNA1 P78396 9/20 0.39
GRM4 Q14833 4/20 0.35
TTK P33981 1/20 0.32
RET P07949 1/20 0.32
KIF5B P33176 1/20 0.32
KDR P35968 1/20 0.32
ETV6 P41212 1/20 0.32
KCNH2 Q12809 1/20 0.32
CCDC6 Q16204 1/20 0.32
TYK2 P29597 1/20 0.32
GRM2 Q14416 1/20 0.32
RIPK2 O43353 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15007036 0.90 CHEK1 (0.42) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL22357 0.83 CHEK1 (0.42) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL15007236 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL15031445 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL15006972 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL21922 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL29752 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL20640 0.82 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL20972 0.81 CHEK1 (0.35) CHEK1CCNA2CDK2CCNA1GRM4
SCHEMBL15007233 0.81 CHEK1 (0.35) CHEK1CCNA2CDK2CCNA1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed